George A. Kaysen

George Kaysen

Position Title
Professor of Medicine and Biochemistry and Molecular Medicine

Unit
Department of Internal Medicine (Nephrology), School of Medicine
Department of Biochemistry and Molecular Medicine, School of Medicine

GBSF 451 East Health Sciences Drive
Bio

Profile Introduction

Mechanism of hyperlipidemia in renal disease, consequence and cause of inflammation in dialysis, effects of inflammation on vascular endothelial structure and function, regulation of plasma protein composition

Research Interests

Mechanism of hyperlipidemia in renal disease, consequence and cause of inflammation in dialysis, effects of inflammation on vascular endothelial structure and function, regulation of plasma protein composition

Labs

  • Greg Shearer, Davis Campus
  • Tjien Thio, Davis Campus

Professional Societies

  • American Society of Nephrology
  • International Society of Nephrology
  • International Society of Renal Nutrition and Metabolism (President)
  • National Kidney Foundation

Degrees

  • 1965 BS Chemistry Franklin and Marshall College, Pennsylvania
  • 1972 PhD Biochemistry Albert Einstein College of Medicine
  • 1972 1972-73 Intern Albert Einstein College of Medicine
  • 1973 1973-75 Resident Albert Einstein College of Medicine
  • 1972 MD Albert Einstein College of Medicine
  • 1975 1975-1977, Fellow Albert Einstein School of Medicine

Publications

2003 Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales L, Levin NW. Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney International 63(1):315-322.

2002 Prinsen BH, Kaysen GA, Klomp LW, de Boer J, Barrett PH, Thornalley PJ, Battah S, Berger R, Rabelink TJ, der Velden MG. Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate. Clin Biochem. 35(7):545-53.

2002 Rahmati, M.A., Craig, R.G., Homel, P., Kaysen, G.A., Levin, N.W. Serum markers of periodontal disease status and inflammation in hemodialysis patients. American Journal of Kidney Diseases. 40(5): 983-89.

2002 Beddhu, S., Kaysen, G.A., Yan, G., Sarnak, M., Agodoa, L., Ornt, D., Cheung, A.K. Association of serum albumin and atheroschlerosis in chronic hemodialysis patients. American Journal of Kidney Diseases. 40(4): 721-27.

2002 Kaysen, G.A., Levin, N.W. Why measure serum albumin levels? Journal of Renal Nutrition. 12(3): 148-50.

2002 Kaysen, G.A., Dubin, J.A., Muller, H.G., Mitch, W.E., Rosales, L.M., Levin, N.W. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney International. 61(6): 2240-49.

2002 Kaysen, G.A. Role of inflammation and its treatment in ESRD patients. Blood Purification. 20(1): 70-80.

2001 Kaysen, G.A., Dubin, J.A., Muller, H.G., Mitch,W.E., Levin, N.W. Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney International. 60(6): 2360-66.

Tags